tiprankstipranks

David Happel Insider Profile

11 Followers
David Happel, CCO at Raptor Pharmaceutical Corp., holds 5.23K shares in Raptor Pharmaceutical Corp. (Ticker: RPTP), holds 5.09K shares in Horizon Therapeutics (Ticker: HZNP), holds 639.20K shares in Sagimet Biosciences, Inc. Class A (Ticker: SGMT).
tipranks
David Happel

David Happel
Raptor Pharmaceutical Corp. (RPTP)
CCO

Ranked #63,513 out of 97,997 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-12.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of David Happel's holdings

Insider Roles

Sagimet Biosciences, Inc. Class A
(SGMT)
President & CEO, Director
Roles that David Happel holds in companies

Most Profitable Insider Trade

Stock:
Sagimet Biosciences, Inc. Class A
(SGMT)
Rating:Informative Buy
Date:Nov 20, 2023 - Today
Return:+10.60%
The most profitable trade made by David Happel

David Happel's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
RPTP
Raptor Pharmaceutical Corp.
Mar 03, 2016
Uninformative Sell
1.98K
$47.06K
HZNP
Horizon Therapeutics
$591.85K
Sagimet Biosciences, Inc. Class A
Mar 28, 2024
President & CEO, Director
Informative Buy
63.65K
$2.17M
List of latest transactions for each holding click on a transaction to see David Happel's performance on stock

David Happel insider profile FAQ

What is the percentage of profitable transactions made by David Happel?
The percentage of profitable transactions made by David Happel is 33%.
    What is the average return per transaction made by David Happel?
    The average return per transaction made by David Happel is -12.00%.
      What stocks does David Happel hold?
      David Happel holds: RPTP, HZNP, SGMT stocks.
        What was David Happel’s latest transaction?
        David Happel latest transaction was an Uninformative Sell of $1.98K.
          What was David Happel's most profitable transaction?
          David Happel’s most profitable transaction was an Informative Buy of SGMT stock on November 20, 2023. The return on the trade was 10.60%.
            What is David Happel's role in Raptor Pharmaceutical Corp.?
            David Happel's role in Raptor Pharmaceutical Corp. is CCO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.